Any time the word “advanced” goes before a type of cancer, that’s not good. Advanced cancers have either spread, come back or no longer respond to therapy.

One of the biggest concerns for diabetes patients is vision loss. While steroids and laser treatment can help when eye problems get severe, medications may offer clearer results.

Good news has been released for women whose cervical cancer has spread, returned or no longer responds to therapy. A drug used for a number of different cancers may help these women live longer.

At an international oncology meeting, new data has been presented on drugs that treat kidney cancer. The results have been released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.

Cancer tumors need an entire support structure of blood vessels to get the nutrients it needs to survive. A drug that goes after the support structure in metastatic breast cancer slows the progression of the disease, but doesn't prolong life.

HER2 stands for human epidermal growth factor receptor 2 and is most often seen as HER2 . It's a cell protein that stimulates cancer cells to grow. Its presence usually indicates an aggressive cancer.

Treating colorectal cancer that has spread to other sites involves a combination of chemotherapies. One regimen that's been in use has been proven to extend life and is likely to become the standard of care. A phase III trial has found that continued use of Avastin ( bevacizumab ), along with different first- and second-line chemotherapies, prevents the disease from progressing by 1.6 months longer than traditional therapy. This research also indicates that people using Avastin lived with advanced colorectal cancer another 1.4 months. Ask your doctor the exact benefits of all th...

A second trial has affirmed that cancer drug Avastin ( bevacizumab ) is an effective cost efficient treatment for patients suffering from age-related macular degeneration (AMD), which can lead to blindness.

Two medications commonly used to treat age-related macular degeneration (AMD) have been found to provide equal treatment benefit in the first long-term study comparing the drugs.  Injectable drugs Avastin ( bevacizumab ), an off-label cancer medication most frequently used to treat AMD, and Lucentis ( ranibizumab ), approved to treat AMD by the U.S. Food and Drug Administration in 2006, both provided similar vision improvements at two years. Get regular vision exams to pinpoint vision loss early. Maureen Maguire, PhD, corresponding author and director of the Center for Preventi...

Cancer treatment has come a long way in the last few decades, and further refinement is a constant process. New research shows that the age of the patient may influence the best drug treatment option.